Each year brings significant changes and challenges in the laws governing the healthcare industry, and 2018 proved to be no exception. The Department of Health and Human Services (HHS) signaled new directions in a number of areas, including a bundle of requests for comments regarding regulatory reform dubbed the “Regulatory Sprint to Coordinated Care,” as well as several key changes in payment policy. The year also included significant developments in False Claims Act (FCA) litigation as well as Department of Justice (DOJ) policy regarding healthcare fraud enforcement. In addition, the opioid crisis gave rise to several noteworthy legal developments and promises more in 2019. And, yet again, as the year ended, the fate of the Affordable Care Act (ACA) hung in the balance.
In an effort to take stock of the year that was and prepare for the challenges that lie ahead, we have prepared short summaries of a number of important developments that affect a broad range of healthcare industry clients. If you would like to learn more about these or other health law issues, please contact any of the attorneys in our Healthcare Practice Group.